Login / Signup

Challenges in analyzing clinical trials testing Bruton tyrosine-kinase-inhibitora in chronic lymphocytic leukaemia.

Yingqi ShaoNeil E KayRobert Peter GaleZhi-Wei Liang
Published in: Leukemia (2024)
Keyphrases
  • tyrosine kinase
  • clinical trial
  • epidermal growth factor receptor
  • phase ii
  • open label
  • randomized controlled trial
  • phase iii
  • double blind
  • study protocol
  • placebo controlled